InvestorsHub Logo
Followers 2
Posts 597
Boards Moderated 0
Alias Born 05/29/2011

Re: biotech_researcher post# 57497

Thursday, 12/18/2014 11:01:48 AM

Thursday, December 18, 2014 11:01:48 AM

Post# of 80490
br- we can always count on you to put the most negative slant on any available information.

The future of ponatinib is yet to be told. More sophisticated dosing schedules and combinations will undoubtedly develop so that patients can benefit from the power it has.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.